Paris, France – May 9, 2025 – Coave Therapeutics (“Coave”), a company pioneering the future of genetic medicines, today announced the launch of coAAV-CSF-01, a novel CNS-targeted gene therapy capsid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback